Sunshine Biopharma (SBFM) Other financing activities (2018 - 2026)
Sunshine Biopharma's (SBFM) quarterly Other financing activities came in at $724500.0 in Q4 2025, down 55.23% YoY from $1.6 million in Q4 2024, and down 60.63% on a QoQ basis from $1.8 million in Q2 2025.
Sunshine Biopharma (SBFM) Other financing activities (2018 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 6 years of Other financing activities data on file, last reported at $724500.0 in Q4 2025.
- Quarterly Other financing activities fell 55.23% year-over-year to $724500.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 24.54% YoY) and the FY2025 annual result came in at $2.9 million, down 17.96% from the prior year.
- Other financing activities declined to $724500.0 in Q4 2025, from $1.8 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $13.2 million in Q4 2022 to a low of $1156.0 in Q2 2023.
- A 4-year average of $3.7 million and a median of $1.6 million in 2024 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2024 — Other financing activities plunged 87.74% — and 2025, when it jumped 689.55%.
- Tracing SBFM's Other financing activities over 4 years: stood at $13.2 million in 2022, then slipped by 0.01% to $13.2 million in 2023, then sank by 87.74% to $1.6 million in 2024, then slumped by 55.23% to $724500.0 in 2025.
- The last three Other financing activities figures came in at $724500.0 (Q4 2025), $1.8 million (Q2 2025), and $355297.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Sunshine Biopharma | 1.53 Mn | -12.22 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.72 Mn |
| Jun 30, 2026 | 2.72 Mn |
| Dec 31, 2025 | 724,500.00 |
| Dec 31, 2025 | 724,500.00 |
| Jun 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 355,297.00 |
| Mar 31, 2025 | 355,297.00 |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 45,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 13.20 Mn |
| Dec 31, 2023 | 13.20 Mn |
| Jun 30, 2023 | 1,156.00 |
| Jun 30, 2023 | 1,156.00 |
| Dec 31, 2022 | 13.20 Mn |
| Dec 31, 2022 | 13.20 Mn |